Océanie · Bourse & Finance · Stockhead

Long Shortz Optiscan: FDA submission opens path to US commercialisation

Publié par Stockhead · Australie il y a 3 h

US FDA 510(k) submission for InForm digital pathology device is a major milestone towards potential US commercialisation. ... Read More The post Long Shortz Optiscan: FDA…

Lire l'article complet sur Stockhead Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stockhead.com.au)

Long Shortz Optiscan: FDA submission opens path to US commercialisation

À lire aussi

Almost $60b wiped from ASX in bond-linked bloodbath

Here are the top 10 ASX 200 shares today

The death of the free quote: Why tradies are charging customers upfront

The Reverse Centaur

Doctors and allied health professionals walk off job en masse amid pay disputes

AMP, CFS and Vision Super get the Epic Retirement Tick

Long Shortz Optiscan: FDA submission opens path to US commercialisation

Partager

À lire aussi

Almost $60b wiped from ASX in bond-linked bloodbath

Here are the top 10 ASX 200 shares today

The death of the free quote: Why tradies are charging customers upfront

The Reverse Centaur

Doctors and allied health professionals walk off job en masse amid pay disputes

AMP, CFS and Vision Super get the Epic Retirement Tick